Japanese Foundation for Cancer Research

9/20

9ChemotherapyOutstanding treatment effects with chemotherapyRecently, groundbreaking anti-cancer drugs have been developed, including molecularly-targeted therapies, dramatically expanding the treatment options available for patients. The Cancer Institute Hospital works in close collaboration with the Cancer Chemotherapy Center, where new anti-cancer drugs are under study. Research at the Cancer Chemotherapy Center is currently focused on such areas as cancer metastasis, drug-resistant cancers, and stem-cell therapy. 　In addition, the Cancer Insititute Hospital is now conducting a clinical study to improve overall survival in patients using multiple-drug chemotherapy. Another clinical study at the Hospital is underway to test a new chemotherapeutic method on advanced-cancer patients who have shown poor response to existing chemotherapy regimens. It represents a novel approach toward developing the next generation of chemotherapy. Japan’s largest ambulatory chemotherapy centerDue to improvements in chemotherapy, cancer treatment has shifted from inpatient to outpatient settings. The Ambulatory Treatment Center (ATC), the outpatient chemotherapy treatment center of the Hospital, is one of the largest in Japan. The ATC features reclining chairs and TVs in a relaxed and comfortable atmosphere that allows patients to maintain a normal social life while receiving their chemotherapy. ‘’Shunji Takahashi, M.D.Department Director of Medical OncologyTreatment with anti-cancer drugs requires a long-term regimen to achieve the most effective treatment or to reduce adverse drug reactions. For that purpose, doctors, nurses, and pharmacists work as a team to provide treatment.

※こ�?�ペ�?�ジを正しく表示するにはFlashPlayer10.2以上が�?要で�?